Cellebrite Announces First-Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
Cellebrite (CLBT) PT Raised to $14 at JPMorgan
May 23, 2024 4:46 PM EDTJPMorgan analyst Doug Bruehl raised the price target on Cellebrite (NASDAQ: CLBT) to $14.00 (from $12.00) while maintaining a Overweight rating.
The analyst comments "Healthy results with subscription conversion cycle ahead. Cellebrite reported a solid quarter with ARR growth of 27% y/y, relatively in line with consensus expectations. The company is in early stages of converting its installed base... More
